Curated Wealth Partners LLC Makes New $242,000 Investment in HealthEquity, Inc. (NASDAQ:HQY)

Curated Wealth Partners LLC purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,521 shares of the company’s stock, valued at approximately $242,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HQY. Wasatch Advisors LP grew its position in HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after purchasing an additional 483,269 shares during the last quarter. State Street Corp increased its position in shares of HealthEquity by 0.8% in the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after acquiring an additional 23,613 shares during the period. Clearbridge Investments LLC raised its stake in HealthEquity by 1.9% in the 2nd quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after acquiring an additional 43,491 shares during the last quarter. Mackenzie Financial Corp lifted its position in HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after acquiring an additional 325,906 shares during the period. Finally, Geode Capital Management LLC grew its stake in HealthEquity by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock valued at $170,197,000 after purchasing an additional 15,145 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. The Goldman Sachs Group initiated coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price for the company. BTIG Research lifted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Royal Bank of Canada increased their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price for the company. Finally, JMP Securities increased their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Stock Performance

Shares of HQY stock opened at $106.88 on Friday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $107.87. The business’s 50 day moving average is $99.60 and its two-hundred day moving average is $87.35. The company has a market capitalization of $9.26 billion, a P/E ratio of 98.06, a P/E/G ratio of 1.86 and a beta of 0.54.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the firm posted $0.40 earnings per share. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Transactions at HealthEquity

In related news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the transaction, the director now owns 66,469 shares in the company, valued at $6,750,591.64. The trade was a 11.04 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 34,289 shares of company stock valued at $3,355,718 over the last 90 days. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.